tiprankstipranks
Trending News
More News >
Cellectis SA (CLLS)
NASDAQ:CLLS
US Market
Advertisement

Cellectis SA (CLLS) Technical Analysis

Compare
952 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
4Neutral
8Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Cellectis SA’s (CLLS) Moving Averages Convergence Divergence (MACD) indicator is 0.09, suggesting Cellectis SA is a Buy.
Cellectis SA’s (CLLS) 20-Day exponential moving average is 2.65, while Cellectis SA’s (CLLS) share price is $2.57, making it a Sell.
Cellectis SA’s (CLLS) 50-Day exponential moving average is 2.35, while Cellectis SA’s (CLLS) share price is $2.57, making it a Buy.

Cellectis SA (CLLS) Pivot Points

Sep 01, 2025, 11:28 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.47
2.53
2.56
2.62
2.65
2.71
2.75
Fibonacci
2.53
2.56
2.58
2.62
2.65
2.67
2.71
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cellectis SA (CLLS) Moving Averages

Sep 01, 2025, 11:28 AM
Period
Simple
Exponential
MA5
2.62Sell
2.64Sell
MA10
2.74Sell
2.68Sell
MA20
2.74Sell
2.65Sell
MA50
2.25Buy
2.35Buy
MA100
1.85Buy
2.05Buy
MA200
1.73Buy
1.92Buy
Cellectis SA’s (CLLS) 10-Day exponential moving average is 2.68, while Cellectis SA’s (CLLS) share price is $2.57, making it a Sell.
Cellectis SA’s (CLLS) 100-Day exponential moving average is 2.05, while Cellectis SA’s (CLLS) share price is $2.57, making it a Buy.
Cellectis SA’s (CLLS) stock price is $2.57 and Cellectis SA’s (CLLS) 50-day simple moving average is 2.25, creating a Buy signal.
Cellectis SA’s (CLLS) stock price is $2.57 and Cellectis SA’s (CLLS) 100-day simple moving average is 1.85, creating a Buy signal.
Cellectis SA’s (CLLS) stock price is $2.57 and Cellectis SA’s (CLLS) 200-day simple moving average is 1.73, creating a Buy signal.

Cellectis SA (CLLS) Technical Indicators

Sep 01, 2025, 11:28 AM
Name
Value
Implied Action
RSI (14)
49.52
Neutral
STOCH (9,6)
10.26
Buy
STOCHRSI (14)
13.76
Buy
MACD (12,26)
0.09
Buy
ADX (14)
25.41
Neutral
Williams %R
-98.08
Buy
CCI (14)
-90.35
Neutral
ATR (14)
0.20
-
Ultimate Oscillator
37.36
Neutral
ROC
-3.02
Sell
Cellectis SA’s (CLLS) Relative Strength Index (RSI) is 49.52, creating a Neutral signal.
Cellectis SA’s (CLLS) Trend Strength Indicator (ADX) is 25.41, creating a Neutral signal.
Cellectis SA’s (CLLS) Commodity Channel Index (CCI) is -90.35, creating a Neutral signal.
Cellectis SA’s (CLLS) Price Rate of Change (ROC) is -3.02, creating a Sell signal.

FAQ

Is CLLS a Buy, Hold, or Sell?
Based on CLLS’s technical indicators, CLLS is a Hold.
    What is CLLS’s RSI (14)?
    CLLS’s RSI (14) is 49.52, which suggests CLLS is a Neutral.
      What is CLLS’s MACD?
      CLLS’s MACD is 0.09, which suggests CLLS is a Buy.
        What is CLLS’s 5-day moving average?
        CLLS’s 5-day moving average is 2.62, which suggests CLLS is a Sell.
          What is CLLS’s 20-day moving average?
          CLLS 20-day moving average is 2.74, which suggests CLLS is a Sell.
            What is CLLS’s 50-day moving average?
            CLLS’s 50-day moving average is 2.25, which suggests CLLS is a Buy.
              What is CLLS’s 200-day moving average?
              CLLS’s 200-day moving average is 1.73, which suggests CLLS is a Buy.
                What is CLLS’s Williams % R (14)?
                CLLS’s Williams % R (14) is -98.08, which suggests CLLS is a Buy.
                  What is CLLS’s CCI (14)?
                  CLLS’s CCI (14) is -90.35, which suggests CLLS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis